Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Total 13F shares
-
32,746,950
-
Share change
-
-135,006
-
Total reported value
-
$872,755,662
-
Put/Call ratio
-
17%
-
Price per share
-
$26.65
-
Number of holders
-
239
-
Value change
-
+$25,427
-
Number of buys
-
113
-
Number of sells
-
126
Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2025
As of 30 Sep 2025,
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by
239 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,746,950 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, TD Asset Management Inc, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, FULLER & THALER ASSET MANAGEMENT, INC., Boston Trust Walden Corp, Epoch Investment Partners, Inc., GEODE CAPITAL MANAGEMENT, LLC, and MARSHALL WACE, LLP.
This page lists
239
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.